(E)- and (Z)-3-Ferrocenylmethylidene-1,3-dihydro-2H-indol-2-ones 1 have been structurally modified in order to explore SAR against a range of kinases. Of note is the submicromolar to low micromolar inhibition of DYRK3 and 4 by a number of complexes. Screening using Xenopus embryos showed some of the compounds to have potent antiangiogenisis activity.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/c1mt00017a | DOI Listing |
Publication Analysis
Top Keywords
synthesis evaluation
4
evaluation metallocene
4
metallocene methylidene-13-dihydro-2h-indol-2-ones
4
methylidene-13-dihydro-2h-indol-2-ones kinase
4
kinase inhibitors
4
inhibitors z-3-ferrocenylmethylidene-13-dihydro-2h-indol-2-ones
4
z-3-ferrocenylmethylidene-13-dihydro-2h-indol-2-ones structurally
4
structurally modified
4
modified order
4
order explore
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!